Brandl Talos advises biotech start-up Sarcura on EUR 2.5 million seed financing round

• Venture Capital & Start Ups from Adrian Zuschmann, Markus Arzt

Vienna, November 19, 2020 – Sarcura GmbH, a Vienna-based biotech start-up, secures €2.5 million in its seed funding round from renowned venture capital investors including IST Cube, Nina Capital and Axilium Capital.

Sarcura is working on the development of an innovative manufacturing platform for autologous cell therapy. The interdisciplinary founding team combines microfluidics and microchip technology to revolutionize the industrial manufacturing of personalized cell therapy. In doing so, the company aims to fully automate the manufacturing of highly potent, live drugs through real-time process and inline quality control at the cellular level. Sarcura will use the investment to advance the development of its first product, a GMP cell sorter.

The Brandl & Talos transaction team consisted of Markus Arzt and Adrian Zuschmann.

» We are very pleased that Sarcura trusted our expertise in their seed financing round. The start-up has a promising founding team and aims to make a significant contribution to the industrial production of personalized cell therapy. We hope that Sarcura will be able to successfully launch their venture through the investment. «

Markus Arzt

The team

Adrian Zuschmann

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

)

Attorney at Law / Corporate Law & Transactions, Venture Capital & Start Ups, Fund Formation

Adrian advises and represents Austrian and international institutional and strategic investors, founders and (start-up) companies in the context of financing rounds, M&A, investments in portfolio companies and exit transactions.

A second focus is advising Austrian fund initiatives on the formation and structuring of funds as well as in connection with their ongoing operational matters.

Queen Mary University of London (MSc Law & Finance 2020)
University of Vienna, Faculty of Law (Magister iuris 2015)

Markus Arzt

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 1
            [name] => Associated Partner
            [slug] => associated-partner
            [term_group] => 0
            [term_taxonomy_id] => 1
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 4
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

)

Attorney at Law / Fund Formation, Capital Markets, Venture Capital & Start Ups, Corporate Law & Transactions

In recent years, Markus has spearheaded various large international transactions and is a respected venture capital and private equity expert.

University of Vienna, Faculty of Law (Mag. iur. 2012)

Latest insights into
Venture Capital & Start Ups

BRANDL TALOS advises Pride Capital Partners on the acquisition of a minority stake in RUBICON alongside RSM Ebner Stolz

Press release • Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann, Julia Strimitzer

Pride Capital Partners, with offices in Amsterdam, Cologne, and Copenhagen, is a hybrid private equity & debt investor focusing on the software and IT industry. With the acquisition of a minority stake in Vienna-based RUBICON Group, Pride completes its first Austrian investment.

BRANDL TALOS advises Telos Impact on EUR 12 million Series A Financing Round of Kern Tec

• Venture Capital & Start Ups from Roman Rericha, Stephan Strass, Adrian Zuschmann, Daniel Habich

BRANDL TALOS has advised Telos Impact as lead investor on the EUR 12 million Series A financing round of Kern Tec GmbH. The financing round was led by Telos Impact, a leading actor in impact investing, with participation from the PeakBridge Growth II Fund and the European Innovation Council (EIC) Fund.

BRANDL TALOS advises on sale of ready2order to Zucchetti Group

Press release • Venture Capital & Start Ups from Roman Rericha, Markus Arzt

BRANDL TALOS advised as sell-side lead counsel on the sale of ready2order GmbH, the Austrian market leader in cloud-based point-of-sale systems, to the Italian IT market leader Zucchetti.